<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE trials [
<!ELEMENT trials (trial+)>

<!ELEMENT trial (main,contacts,countries,criteria,health_condition_code,health_condition_keyword,intervention_code,
          intervention_keyword,primary_outcome,secondary_outcome,secondary_sponsor,secondary_ids,source_support,ethics_reviews)>

<!ELEMENT main (trial_id,utrn?,reg_name,date_registration,primary_sponsor,public_title,acronym?,scientific_title,scientific_acronym?,
          date_enrolment,type_enrolment,target_size,recruitment_status,url?,study_type,study_design,phase,hc_freetext?,i_freetext?,results_actual_enrolment,results_date_completed,results_url_link,results_summary,           results_date_posted,results_date_first_publication,results_baseline_char,results_participant_flow,results_adverse_events,results_outcome_measures,results_url_protocol,results_IPD_plan, results_IPD_description)>
<!ELEMENT trial_id (#PCDATA)>
<!ELEMENT utrn (#PCDATA)>
<!ELEMENT reg_name (#PCDATA)>
<!ELEMENT date_registration (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT primary_sponsor (#PCDATA)>
<!ELEMENT public_title (#PCDATA)>
<!ELEMENT acronym (#PCDATA)>
<!ELEMENT scientific_title (#PCDATA)>
<!ELEMENT scientific_acronym (#PCDATA)>
<!ELEMENT date_enrolment (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT type_enrolment (#PCDATA)>
<!ELEMENT target_size (#PCDATA)>
<!ELEMENT recruitment_status (#PCDATA)><!-- Pending,Recruiting,Suspended,Complete,Other -->
<!ELEMENT url (#PCDATA)>
<!ELEMENT study_type (#PCDATA)><!-- interventional,observational -->
<!ELEMENT study_design (#PCDATA)>
<!ELEMENT phase (#PCDATA)>
<!ELEMENT hc_freetext (#PCDATA)>
<!ELEMENT i_freetext (#PCDATA)>
<!ELEMENT results_actual_enrolment (#PCDATA)>
<!ELEMENT results_date_completed (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_url_link (#PCDATA)>
<!ELEMENT results_summary (#PCDATA)>
<!ELEMENT results_date_posted (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_date_first_publication (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_baseline_char (#PCDATA)>
<!ELEMENT results_participant_flow (#PCDATA)>
<!ELEMENT results_adverse_events (#PCDATA)>
<!ELEMENT results_outcome_measures (#PCDATA)>
<!ELEMENT results_url_protocol (#PCDATA)>
<!ELEMENT results_IPD_plan (#PCDATA)>
<!ELEMENT results_IPD_description (#PCDATA)>


<!ELEMENT contacts (contact+)>
<!ELEMENT contact (type,firstname,middlename,lastname,address,city,country1,zip,telephone,email,affiliation)>
<!ELEMENT type (#PCDATA)><!-- Public,Scientific -->
<!ELEMENT firstname (#PCDATA)>
<!ELEMENT middlename (#PCDATA)>
<!ELEMENT lastname (#PCDATA)>
<!ELEMENT address (#PCDATA)>
<!ELEMENT city (#PCDATA)>
<!ELEMENT country1 (#PCDATA)>
<!ELEMENT zip (#PCDATA)>
<!ELEMENT telephone (#PCDATA)>
<!ELEMENT email (#PCDATA)>
<!ELEMENT affiliation (#PCDATA)>

<!ELEMENT countries (country2+)>
<!ELEMENT country2 (#PCDATA)>

<!ELEMENT criteria (inclusion_criteria,agemin,agemax,gender,exclusion_criteria)>
<!ELEMENT inclusion_criteria (#PCDATA)>
<!ELEMENT agemin (#PCDATA)>
<!ELEMENT agemax (#PCDATA)>
<!ELEMENT gender (#PCDATA)>
<!ELEMENT exclusion_criteria (#PCDATA)>

<!ELEMENT health_condition_code (hc_code+)>
<!ELEMENT hc_code (#PCDATA)>

<!ELEMENT health_condition_keyword (hc_keyword+)>
<!ELEMENT hc_keyword (#PCDATA)>

<!ELEMENT intervention_code (i_code+)>
<!ELEMENT i_code (#PCDATA)>

<!ELEMENT intervention_keyword (i_keyword+)>
<!ELEMENT i_keyword (#PCDATA)>

<!ELEMENT primary_outcome (prim_outcome+)>
<!ELEMENT prim_outcome (#PCDATA)>

<!ELEMENT secondary_outcome (sec_outcome+)>
<!ELEMENT sec_outcome (#PCDATA)>

<!ELEMENT secondary_sponsor (sponsor_name+)>
<!ELEMENT sponsor_name (#PCDATA)>

<!ELEMENT secondary_ids (secondary_id+)>
<!ELEMENT secondary_id (sec_id,issuing_authority)>
<!ELEMENT sec_id (#PCDATA)>
<!ELEMENT issuing_authority (#PCDATA)>

<!ELEMENT source_support (source_name+)>
<!ELEMENT source_name (#PCDATA)>

<!ELEMENT ethics_reviews (ethics_review+)>
<!ELEMENT ethics_review (status,approval_date,contact_name,contact_address,contact_phone,contact_email)>
<!ELEMENT status (#PCDATA)><!-- Not approved,Approved,NA -->
<!ELEMENT approval_date (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT contact_name (#PCDATA)>
<!ELEMENT contact_address (#PCDATA)>
<!ELEMENT contact_phone (#PCDATA)>
<!ELEMENT contact_email (#PCDATA)>
]>
<trials>
  <trial>
    <main>
      <trial_id>IRCT20131205015665N3</trial_id>
      <utrn></utrn>
      <reg_name>IRCT</reg_name>
      <date_registration>2020-05-04</date_registration>
      <primary_sponsor>Esfahan University of Medical Sciences</primary_sponsor>
      <public_title>Evaluation of Antibacterial Suture Efficacy on Reduction of Bacterial Adhesion in Impacted Lower Third Molar Surgery</public_title>
      <acronym></acronym>
      <scientific_title>Evaluation of the Bacterial Species and the Mean Number of Bacterial Colonies on Vicryl and Antibacterial Vicryl Sutures Used In Mandibular Third Molar Surgery</scientific_title>
      <scientific_acronym></scientific_acronym>
      <date_enrolment>2019-05-10</date_enrolment>
      <type_enrolment>anticipated</type_enrolment>
      <target_size>30</target_size>
      <recruitment_status>Complete</recruitment_status>
      <url>https://irct.ir/trial/46725</url>
      <study_type>interventional</study_type>
      <study_design>Randomization: Randomized, Blinding: Double blinded, Placebo: Not used, Assignment: Parallel, Purpose: Treatment, Randomization description: pseudorandomization will be done in this study. after considering an ID for each patient number from 1 to 27, in patients with an odd ID number, vicryl suture is placed in the mesial part and antibacterial vicryl suture in the distal part of the flap. in patients with an even ID number, the antibacterial suture is placed in the mesial part of the flap, while the vicryl suture is placed in the distal part, Blinding description: for blinding the participants: they will not be aware of the exact location of the vicryl and vicryl plus sutures in the mesial and distal part of the flap.

for blinding the surgeon: both violet-colored suture materials will be peeled open out of the sight of the surgeon and then given o him for placing the sutures in the mesial and distal part of the flap.

for blinding the technician of the microbiological laboratory: tubes containing the suture materials, will be coded as (1) for vicryl and (2) for vicryl plus .</study_design>
      <phase>N/A</phase>
      <hc_freetext>comparison of mean number of bacterial colonies and predominant species on antibacterial vicryl and vicryl sutures.</hc_freetext>
      <i_freetext>Intervention 1: Intervention group 1: 27 patients selected between May and July 2019 and January 2019 among patients in the dentistry faculty of Isfahan university of medical sciences, Isfahan, Iran. After achieving local anesthesia by lidocaine 2% with epinephrine1:80000, a mucoperiosteal flap is elevated and the third molar tooth is extracted. After that, an interrupted vicryl suture is randomly placed in the mesial or distal part of the flap. Location of each suture for each patient is mentioned in patient’s form (i.e. “1M” means vicryl suture in mesial and “2D" means antibacterial vicryl suture in distal) After 1 week, the suture is removed and sent to the microbiological laboratory in less than 1 hour, while protected in saline. the suture is transferred to the thioglycolate culture media and processed within 1 hour. For each sample, a one-tenth diluted solution with 0.9% NaCl is made and 100µL of it was used on blood agar culture medium and then Incubation is done in 37 degrees of temperature for 2-4 days. Gram coloring is done and cellular morphology is assessed under an optical microscope. Intervention 2: Intervention group 2: 27 patients selected between May and July 2019 and January 2019 among patients in the dentistry faculty of Isfahan university of medical sciences, Isfahan, Iran. After achieving local anesthesia by lidocaine 2% with epinephrine1:80000, a mucoperiosteal flap is elevated and the third molar tooth is extracted. After that, an interrupted antibacterial vicryl suture is randomly placed in the mesial or distal part of the flap. Location of each suture for each patient is mentioned in patient’s form (i.e. “1M” means vicryl suture in mesial and “2D" means antibacterial vicryl suture in distal) After 1 week, the suture is removed and sent to the microbiological laboratory in less than 1 hour, while protected in saline. the suture is transferred to the thioglycolate culture media and processed within 1 hour. For each sample, a one-tenth diluted solution with 0.9% NaCl is made and 100µL of it was used on blood agar culture medium and then Incubation is done in 37 degrees of temperature for 2-4 days. Gram coloring is done and cellular morphology is assessed under an optical microscope.</i_freetext>
      <results_actual_enrolment></results_actual_enrolment>
      <results_date_completed></results_date_completed>
      <results_url_link></results_url_link>
      <results_summary></results_summary>
      <results_date_posted></results_date_posted>
      <results_date_first_publication></results_date_first_publication>
      <results_baseline_char></results_baseline_char>
      <results_participant_flow></results_participant_flow>
      <results_adverse_events></results_adverse_events>
      <results_outcome_measures></results_outcome_measures>
      <results_url_protocol></results_url_protocol>
      <results_IPD_plan>No - There is not a plan to make this available</results_IPD_plan>
      <results_IPD_description>Justification or reason for not sharing IPD is There is no further information</results_IPD_description>
    </main>
    <contacts>
      <contact>
        <type>public</type>
        <firstname>Milad Etemadi Shalamzari</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Department of oral and maxillofacial surgery, dentistry faculty, Isfahan university of medical sciences, Hezar-jerib st., Isfahan, Iran.</address>
        <city>Isfahan</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>81746-73461</zip>
        <telephone>+98 31 3792 5581</telephone>
        <email>etemadi@dnt.mui.ac.ir</email>
        <affiliation>Esfahan University of Medical Sciences</affiliation>
      </contact>
      <contact>
        <type>scientific</type>
        <firstname>Milad Etemadi Shalamzari</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Department of oral and maxillofacial surgery, dentistry faculty, Isfahan university of medical sciences, Hezar-jerib st., Isfahan, Iran.</address>
        <city>Isfahan</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>81746-73461</zip>
        <telephone>+98 31 3792 5581</telephone>
        <email>etemadi@dnt.mui.ac.ir</email>
        <affiliation>Esfahan University of Medical Sciences</affiliation>
      </contact>
    </contacts>
    <countries>
      <country2>Iran (Islamic Republic of)</country2>
    </countries>
    <criteria>
      <inclusion_criteria>having type A mesioangular mandibular third molar indicated for surgical removal
having appropriate radiographic imaging
age between 18-30
absence of obvious infection and/or extensive caries lesion in the oral cavity</inclusion_criteria>
      <agemin>18 years</agemin>
      <agemax>30 years</agemax>
      <gender>Both</gender>
      <exclusion_criteria>systemic health problems
systemic or oral medication affecting normal oral microbial flora and colonization
smoking and drug addiction
alcohol addiction
presence of intraoral inflammation before the surgery
pregnancy and lactation
known or suspected allergy to suture and other materials using in this study
presence of removable prosthesis in the oral cavity
loss of sutures before suture removal appointment
presence of infection after surgery or any other situation with the need for antibiotic therapy</exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code></hc_code>
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword></hc_keyword>
    </health_condition_keyword>
    <intervention_code>
      <i_code>Treatment - Other</i_code>
      <i_code>Treatment - Other</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword>Intervention group 1: 27 patients selected between May and July 2019 and January 2019 among patients in the dentistry faculty of Isfahan university of medical sciences, Isfahan, Iran. After achieving local anesthesia by lidocaine 2% with epinephrine1:80000, a mucoperiosteal flap is elevated and the third molar tooth is extracted. After that, an interrupted vicryl suture is randomly placed in the mesial or distal part of the flap. Location of each suture for each patient is mentioned in patient’s form (i.e. “1M” means vicryl suture in mesial and “2D" means antibacterial vicryl suture in distal) After 1 week, the suture is removed and sent to the microbiological laboratory in less than 1 hour, while protected in saline. the suture is transferred to the thioglycolate culture media and processed within 1 hour. For each sample, a one-tenth diluted solution with 0.9% NaCl is made and 100µL of it was used on blood agar culture medium and then Incubation is done in 37 degrees of temperature for 2-4 days. Gram coloring is done and cellular morphology is assessed under an optical microscope.</i_keyword>
      <i_keyword>Intervention group 2: 27 patients selected between May and July 2019 and January 2019 among patients in the dentistry faculty of Isfahan university of medical sciences, Isfahan, Iran. After achieving local anesthesia by lidocaine 2% with epinephrine1:80000, a mucoperiosteal flap is elevated and the third molar tooth is extracted. After that, an interrupted antibacterial vicryl suture is randomly placed in the mesial or distal part of the flap. Location of each suture for each patient is mentioned in patient’s form (i.e. “1M” means vicryl suture in mesial and “2D" means antibacterial vicryl suture in distal) After 1 week, the suture is removed and sent to the microbiological laboratory in less than 1 hour, while protected in saline. the suture is transferred to the thioglycolate culture media and processed within 1 hour. For each sample, a one-tenth diluted solution with 0.9% NaCl is made and 100µL of it was used on blood agar culture medium and then Incubation is done in 37 degrees of temperature for 2-4 days. Gram coloring is done and cellular morphology is assessed under an optical microscope.</i_keyword>
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>Mean number of bacterial colonies (cfu/ml) on vicryl and antibacterial vicryl suture materials. Timepoint: 1 week after surgery. Method of measurement: calculation of mean number of bacterial colonies grown in blood agar culture medium.</prim_outcome>
      <prim_outcome>Determining the predominant species. Timepoint: 1 week after surgery. Method of measurement: gram coloring.</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome></sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name></sponsor_name>
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id></sec_id>
        <issuing_authority></issuing_authority>
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>Esfahan University of Medical Sciences</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2019-05-07</approval_date>
        <contact_name>Ethics committee of Isfahan university of medical sciences</contact_name>
        <contact_address>oral and maxillofacial surgery department, dentistry faculty, Isfahan university of medical sciences,Hezar-jerib st., Isfahan, Iran. Isfahan Isfehan Iran (Islamic Republic of)</contact_address>
        <contact_phone></contact_phone>
        <contact_email></contact_email>
      </ethics_review>
    </ethics_reviews>
  </trial>
</trials>
